Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer
LRG1 significantly predicted 3-year overall survival in patients with metastatic breast cancer, supporting its potential as a prognostic biomarker.
Authors
- Axel Muendlein (ORCID: https://orcid.org/0000-0002-5582-4125)
- Christine Heinzle
- Kathrin Geiger (ORCID: https://orcid.org/0009-0005-1623-3938)
- Tobias Dechow (ORCID: https://orcid.org/0000-0001-8976-7328)
- Andreas Leiherer (ORCID: https://orcid.org/0000-0003-3776-5704)
- Patrick Reimann (ORCID: https://orcid.org/0000-0001-8387-3357)
- Eva Maria Brandtner
- Magdalena Benda-Beck
- Thomas Decker
Institutions
- Landeskrankenhaus Feldkirch (AT)
- Ravensburg University of Cooperative Education (DE)
- Private University in the Principality of Liechtenstein (LI)
- Vorarlberg Institute for Vascular Investigation and Treatment (AT)
Publication Details
- Journal
- Oncology Research and Treatment
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1159/000550608
- Primary Topic
- Clusterin in disease pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00